Company: IONQ
Filing Date: 2025-07-07
Form Type: 424B5
Source: 0001193125-25-155901
Chunk: 21

Company: IonQ, Inc.
Filing Date: 2025-07-07
Form: 424B5
Chunk 21
---
 in lieu of the shares of common stock (or other
securities, cash, assets or other property, subject to certain exceptions) issuable upon the exercise of a Warrant prior to such Fundamental Transaction, such shares of common stock (or its equivalent) of the Successor Entity or such other
securities, cash, assets or other property, as applicable, which the holder would have been entitled to receive upon the happening of such Fundamental Transaction had a Warrant been exercised immediately prior to such Fundamental Transaction
(without regard to any limitations on the exercise of a Warrant), as adjusted in accordance with the provisions of the Warrant Agreement. In addition, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of
common stock are entitled to receive cash, securities or other assets or property with respect to or in exchange for shares of common

S-16

stock, we shall make appropriate provision to insure that the holder will thereafter have the right to receive upon an exercise of a Warrant at any time after the consummation of the applicable
Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the common stock (or other securities, cash, assets or other property, subject to certain exceptions) issuable upon the exercise of the Warrant prior to such
Fundamental Transaction, such cash, securities or other assets or property which the holder would have been entitled to receive upon the happening of such Fundamental Transaction had a Warrant been exercised immediately prior to such Fundamental
Transaction (without regard to any limitations on the exercise of a Warrant).

For the purposes of the foregoing description:

“Fundamental Transaction” means: (A) that we shall, directly or indirectly, including through subsidiaries, affiliates or otherwise, in one or more
related transactions, (i) consolidate or merge with or into (whether or not we are the surviving corporation) any person, persons or group (including in a “double dummy” or “holding company” transaction with a subsidiary or
affiliate of ours), or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of our assets and any of our subsidiaries, taken as a whole, to one or more persons or groups (including through such any such person or
group acquiring equity interests of one or more subsidiaries) (other than to us or a wholly-owned subsidiary of ours), or (iii) make, or allow one or more subject entities to make, or allow us to be subject to or have our